We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VABK icon
3051
Virginia National Bankshares
VABK
$243M
-7,173
Closed -$258K
VATE icon
3052
INNOVATE Corp
VATE
$114M
-6,730
Closed -$200K
VBR icon
3053
Vanguard Small-Cap Value ETF
VBR
$37.1B
-115
Closed -$18.3K
VCLT icon
3054
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.83B
-1,937
Closed -$154K
VCSH icon
3055
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
-1,600
Closed -$122K
VDE icon
3056
Vanguard Energy ETF
VDE
$10.1B
-1,469
Closed -$168K
VEGI icon
3057
iShares MSCI Agriculture Producers ETF
VEGI
$159M
-469
Closed -$19.7K
VET icon
3058
Vermilion Energy
VET
$1.73B
-92,627
Closed -$1.2M
VFC icon
3059
VF Corp
VFC
$6.68B
-41,664
Closed -$955K
VGIT icon
3060
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
-11,797
Closed -$707K
VHT icon
3061
Vanguard Health Care ETF
VHT
$18.2B
-535
Closed -$128K
VIAV icon
3062
Viavi Solutions
VIAV
$9.75B
-202,093
Closed -$2.19M
VIGL
3063
DELISTED
Vigil Neuroscience
VIGL
-18,705
Closed -$183K
VIOV icon
3064
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.85B
-229
Closed -$18.5K
VIV icon
3065
Telefônica Brasil
VIV
$22.4B
-250,832
Closed -$1.9M
VIXY icon
3066
ProShares VIX Short-Term Futures ETF
VIXY
$211M
-900
Closed -$163K
VMC icon
3067
Vulcan Materials
VMC
$36.3B
-167,494
Closed -$28.7M
VMD icon
3068
Viemed Healthcare
VMD
$451M
-80,291
Closed -$776K
VNET
3069
VNET Group
VNET
$2.05B
-155,079
Closed -$502K
VNO icon
3070
Vornado Realty Trust
VNO
$7.47B
-203,848
Closed -$3.13M
VNQI icon
3071
Vanguard Global ex-US Real Estate ETF
VNQI
$3.46B
-14,675
Closed -$595K
VOD icon
3072
Vodafone
VOD
$34.9B
-753,756
Closed -$8.32M
VOR icon
3073
Vor Biopharma
VOR
$1.04B
-2,687
Closed -$289K
VPG icon
3074
Vishay Precision Group
VPG
$1.39B
-5,104
Closed -$213K
VRCA icon
3075
Verrica Pharmaceuticals
VRCA
$86.2M
-5,409
Closed -$352K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.